Skip to main content

Home/ Cancer/ Group items matching "head_and_neck" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
Matti Narkia

Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck. - Clin Cancer Res. 2004 Sep 1 - 0 views

clincancerres.aacrjournals.org/...5930

2004 September study research in_vitro EGFR tyrosine_kinase inhibitors inhibitor inhibition TKI TKIs Iressa gefitinib COX-2 celecoxib Celebre3x Celebra head_and_neck_cancer head_and_neck cancer SCCHN SCC HNCA synergy medicine head neck oncology

shared by Matti Narkia on 15 Mar 09 - Cached
  • Matti Narkia on 15 Mar 09
     
    Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck. Chen Z, Zhang X, Li M, Wang Z, Wieand HS, Grandis JR, Shin DM. Clin Cancer Res. 2004 Sep 1;10(17):5930-9. PMID: 15355926
Matti Narkia

A new radiation therapy treatment developed for head and neck cancer patients - 0 views

www.eurekalert.org/...uoh-anr081607.php

new radiation therapy treatment Boron Neutron Capture BNCT news Helsinki Finland head cancer neck medicine radiotherapy medical oncology science imported delicious head_and_neck head_neck SCCHN

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    Most head-and-neck cancers that recur locally after prior full-dose conventional radiation therapy respond to Boron Neutron Capture Therapy (BNCT). These results were obtained in a Phase I/II study at the Helsinki University Hospital, Finland. The scienti
Matti Narkia

Boron Neutron Capture Therapy in the Treatment of Locally Recurred Head and Neck Cancer - International Journal of Radiation Oncology * Biology * Physics - 0 views

www.redjournal.org/...abstract

Boron Neutron Capture Therapy Treatment Locally Recurred Head Neck Cancer bnct hnca radiotherapy radiation recurrence recurrent recurring medicine medline oncology peer-reviewed study science research helsinki finland imported head_and_neck head_nec SCCHN

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    Boron Neutron Capture Therapy in the Treatment of Locally Recurred Head and Neck Cancer. Corrected Proof, 7 August 2007 Leena Kankaanranta, Tiina Seppälä, Hanna Koivunoro, Kauko Saarilahti, Timo Atula, Juhani Collan, Eero Salli, Mika Kortesniemi, Jouni
Matti Narkia

Sulindac Induces Apoptosis and Inhibits Tumor Growth in vivo in Head and Neck Squamous Cell Carcinoma - Entrez PubMed - 0 views

www.ncbi.nlm.nih.gov/...query.fcgi

Sulindac Apoptosis Inhibits Tumor Growth Head Neck Squamous Cell Carcinoma cancer SCC inhibition inhibit imported delicious head_and_neck SCCHN

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    Scheper MA, Nikitakis NG, Chaisuparat R, Montaner S, Sauk JJ. Sulindac Induces Apoptosis and Inhibits Tumor Growth in vivo in Head and Neck Squamous Cell Carcinoma. Neoplasia. 2007 Mar;9(3):192-9. PMID: 17401459 [PubMed - in process]
Matti Narkia

The role of botulinum toxin in the management of head and neck cancer patients - Entrez PubMed - 0 views

www.ncbi.nlm.nih.gov/...query.fcgi

head neck cancer management botulinum toxin science study medicine medline peer-reviewed pubmed imported delicious head_and_neck

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    Laskawi R, Ellies M. The role of botulinum toxin in the management of head and neck cancer patients. Curr Opin Otolaryngol Head Neck Surg. 2007 Apr;15(2):112-6. PMID: 17413413 [PubMed - in process]
Matti Narkia

The challenging integration of platinum compounds, taxanes, and molecular-targeted therapies in the multidisciplinary treatment of squamous cell carcinoma of the head and neck - Entrez PubMed - 0 views

www.ncbi.nlm.nih.gov/...query.fcgi

head neck cancer squamous cell carcinoma multidisciplinary treatment molecular platinum taxanes integration locally advanced chemoradiation chemotherapy therapy science study medicine medline peer-reviewed pubmed scc imported delicious head_and_neck SCCHN

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    Awada A, Ismael G. The challenging integration of platinum compounds, taxanes, and molecular-targeted therapies in the multidisciplinary treatment of squamous cell carcinoma of the head and neck. Curr Opin Oncol. 2007 May;19(3):177-9. PMID: 17414633 [
Matti Narkia

Sham vs. Wham: The Health Insider: The Beverage Yerba Maté May Have Ties to Head and Neck Cancers - 0 views

shamvswham.blogspot.com/...erba-mat-may-have-ties-to.html

Beverage Yerba Maté mate Head Neck Cancer drink herbal herbs tea risk factor consumption nutrition health medicine factors food foods imported delicious head_and_neck head_neck SCCHN

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    "Maté consumption plays a significant and independent role in the development of upper aeodigestive tract cancers," and "Maté drinking should be considered one of the risk factors for cancer of the neck and head."
Matti Narkia

Novel therapy for cancer? from medicineworld.org - 0 views

medicineworld.org/...novel-therapy-for-cancer.html

2009 May medicineworld news Novel therapy new cancer anti-viral drug anti-viral_drug ribavirin eIF4E gene breast breast_cancer prostate prostate_cancer head_and_neck head_and_neck_cancer hnca scchn colon colon_cancer stomach stomach_cancer

shared by Matti Narkia on 14 May 09 - Cached
  • Matti Narkia on 14 May 09
     
    A ground-breaking Canada-wide clinical trial led by Dr. Katherine Borden, at the Institute for Research in Immunology and Cancer (IRIC) of the Universit de Montral, has shown that a common anti-viral drug, ribavirin, can be beneficial in the treatment of cancer patients. Published in the journal Blood (First Edition), the study demonstrates that ribavirin suppresses the activities of the eIF4E gene in patients. This gene is dysregulated in 30 percent of cancers including breast, prostate, head and neck, colon and stomach cancer.
Matti Narkia

The beverage maté: a risk factor for cancer of the head and neck. - Head Neck. 2003 Jul;25(7):595-601 (full text) - 0 views

www3.interscience.wiley.com/...HTMLSTART

2003 July study review epidemiological in_vivo in_vitro humans Mate Maté Ilex_paraguariensis yerba drink cancer risk oral head_and_neck head_and_neck_cancer hnca scchn oropharyngeal nutrition medline cancer_risk risk_factor

shared by Matti Narkia on 23 Apr 09 - No Cached
  • Matti Narkia on 23 Apr 09
     
    The beverage maté: a risk factor for cancer of the head and neck. Goldenberg D, Golz A, Joachims HZ. Head Neck. 2003 Jul;25(7):595-601. Review. PMID: 12808663 DOI: 10.1002/hed.10288
Matti Narkia

Maté: a risk factor for oral and oropharyngeal cancer - Oral Oncol. 2002 Oct;38(7):646-9 - 0 views

www.oraloncology.com/...abstract

2002 October study review epidemiological humans Mate Maté Ilex_paraguariensis yerba drink cancer risk oral head_and_neck head_and_neck_cancer hnca scchn oropharyngeal nutrition medline cancer_risk risk_factor

shared by Matti Narkia on 23 Apr 09 - Cached
  • Matti Narkia on 23 Apr 09
     
    Maté: a risk factor for oral and oropharyngeal cancer. Goldenberg D. Oral Oncol. 2002 Oct;38(7):646-9. Review. PMID: 12167417
Matti Narkia

Selenium and immunocompetence in patients with head and neck cancer. - Biol Trace Elem Res. 2000 Feb - 0 views

www.springerlink.com/...975371n8445363vp

2000 February study clinical_trial rct humans medline nutrition selenium sodium_selenite immunity anergy cell-mediated immune response CMIR head_and_neck cancer head_and_neck_cancer scchn scc hnca therapy treatment supplementation

shared by Matti Narkia on 10 Apr 09 - Cached
  • Matti Narkia on 10 Apr 09
     
    Selenium and immunocompetence in patients with head and neck cancer. Kiremidjian-Schumacher L, Roy M, Glickman R, Schneider K, Rothstein S, Cooper J, Hochster H, Kim M, Newman R. Biol Trace Elem Res. 2000 Feb;73(2):97-111. PMID: 11049203 DOI: 10.1385/BTER:73:2:97
Matti Narkia

Combination Immunotherapy of Squamous Cell Carcinoma of the Head and Neck: A Phase 2 Trial, March 2000, Barrera et al. 126 (3): 345 - Arch Otolaryngol Head Neck Surg - 0 views

archotol.ama-assn.org/...345

200 March study research clinical_trial phase_II phase_II_trial humans head_and_neck cancer head_and_neck_cancer scchn nhca scc natural cytokine mixture IRX-2 Hadden low-dose cyclophosphamide indomethacin zinc contrasuppression immunotherapy nutrition med

shared by Matti Narkia on 10 Apr 09 - Cached
  • Matti Narkia on 10 Apr 09
     
    Combination immunotherapy of squamous cell carcinoma of the head and neck: a phase 2 trial. Barrera JL, Verastegui E, Meneses A, Zinser J, de la Garza J, Hadden JW. Arch Otolaryngol Head Neck Surg. 2000 Mar;126(3):345-51. PMID: 10722007
Matti Narkia

Factors Associated With Clinical Benefit From Epidermal Growth Factor Receptor Inhibitors in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck - OncologySTAT - 0 views

www.oncologystat.com/...noma_of_the_Head_and_Neck.html

2009 October oncologystat study review humans patients EGFR tyrosine kinase inhibitors TKI head_and_neck cancer head_and_neck_cancer hnca scchn recurrent metastatic advanced factors clinical benefits survival medline

shared by Matti Narkia on 08 Oct 09 - Cached
  • Matti Narkia on 08 Oct 09
     
    Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck. Cohen EE, Halpern AB, Kasza K, Kocherginsky M, Williams R, Vokes EE. Oral Oncol. 2009 Oct;45(10):e155-60. Epub 2009 Jul 7. PMID: 19586795
1 - 14 of 14
Showing 20▼ items per page